Capstone Therapeutics Announces Adjournment of Its Annual Meeting of Stockholders and Intention to Reconvene the Meeting on June
June 08 2011 - 12:30PM
Capstone Therapeutics (Nasdaq:CAPS)
(the
"Company") announced that at its Annual Meeting held on
Monday June 6, 2011, there were insufficient shares represented by
person or by proxy at the meeting to establish a quorum for the
election of directors. Accordingly, the meeting was adjourned and
scheduled to reconvene on June 28, 2011 at 10:00 AM PDT at the
Company's offices located at 1275 W. Washington Street, Suite 101,
Tempe, Arizona.
Brokers are no longer allowed to vote without instructions on
the election of directors, making it very important for
stockholders to vote to ensure sufficient votes are present to
achieve a quorum. Without a quorum, the directors cannot be elected
at the reconvened meeting. Stockholders are requested to either
return their proxy cards in the envelope provided with the
previously delivered proxy materials or vote on www.proxyvote.com.
Stockholders may contact their broker to obtain their voter
identification number if they no longer can locate their proxy
card.
Copies of the Company's proxy materials are available at
www.capstonethx.com .
Capstone's corporate headquarters are in Tempe,
Arizona. For more information, please visit the Company's
website: www.capstonethx.com.
The Capstone Therapeutics logo is available
at http://www.globenewswire.com/newsroom/prs/?pkgid=5429
Editor's Note: This press release is also available under
the Investors section of the Company's website at
www.capstonethx.com.
CONTACT: Karen Struck, Investor Relations
(602) 286-5250
kstruck@capstonethx.com
Lauren Glaser - The Trout Group
(415) 392-3310
lglaser@troutgroup.com
Capstone Therapeutics Corp (MM) (NASDAQ:CAPS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Capstone Therapeutics Corp (MM) (NASDAQ:CAPS)
Historical Stock Chart
From Jul 2023 to Jul 2024